Changes to the Code
H.R. 3029 · Nucleic Acid Standards for Biosecurity Act · Referred The text sent to a committee of the other chamber after one chamber passed it.
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
Passed the House · step 3 of 5
42 U.S.C. § 18931 Engineering biology and biometrology
5 changes the bill asks for here, 5 carried out
- Carried out:
in subparagraph (C), by striking
and
after the semicolon;
- Carried out:
by redesignating subparagraph (D) as subparagraph (E); and
- Carried out:
by inserting after subparagraph (C) the following new subparagraph:
(D) best practices, guidelines, and technical standards for risk management associated with engineering biology and biomanufacturing, including risks associated with the use of artificial intelligence; and;
- Carried out:
by redesignating subsections (b) and (c) as subsections (c) and (d), respectively; and
- Carried out:
by inserting after subsection (a) the following new subsection:
(b) Nucleic acid synthesis screening tools and standards.— (1) In general.— The Director, in consultation with heads of Federal agencies the Director considers appropriate, shall carry out measurement research to support the development and improvement of best practices and …
§ 18931(a)–(d)
Start of § 18931 to (a)(1)(A) unchanged ·
(B) technologies for measurement of such biomolecular components and related systems;
(C) new data tools, techniques, and processes to improve engineering biology, biomanufacturing, and biometrology research;[struck: and]
(D) [inserted: best practices, guidelines, and technical standards for risk management associated with engineering biology and biomanufacturing, including risks associated with the use of artificial intelligence; and]
[struck: (D)] [inserted: (E)] other areas of measurement science and technology research determined by the Director to be critical to the development and deployment of engineering biology, biomanufacturing and biometrology;
(2) support activities to inform and expand the development of measurements infrastructure needed to develop technical standards to establish interoperability and facilitate commercial development of biomolecular measurement technology and engineering biology applications;
(3) convene industry, institutions of higher education, nonprofit organizations, Federal laboratories, and other Federal agencies engaged in engineering biology research and development to develop coordinated technical roadmaps for authoritative measurement of the molecular components of the cell;
(4) provide access to user facilities with advanced or unique equipment, services, materials, and other resources to industry, institutions of higher education, nonprofit organizations, and government agencies to perform research and testing;
(5) establish or expand collaborative partnerships or consortia with other Federal agencies engaged in engineering biology research and development, institutions of higher education, Federal laboratories, and industry to advance engineering biology applications; and
(6) support graduate and postgraduate research and training in biometrology, biomanufacturing, and engineering biology.
(b) [inserted: Nucleic acid synthesis screening tools and standards.—]
(1) [inserted: In general.—] [inserted: The Director, in consultation with heads of Federal agencies the Director considers appropriate, shall carry out measurement research to support the development and improvement of best practices and technical standards for biosecurity measures related to nucleic acid synthesis, including the following:]
(A) [inserted: Testing to improve the accuracy, efficacy, and reliability of screening for nucleic acid synthesis.]
(B) [inserted: Best practices, including security and access controls, for operational security and managing sequence-of-concern databases to support such screening.]
(C) [inserted: Technical implementation guidance to ensure such screening is effective and secure.]
(D) [inserted: Conformity-assessment best practices and technical standards.]
(E) [inserted: Methods to evaluate the impact and effectiveness of the implementation of subparagraphs (A) through (D).]
(2) [inserted: Consortium.—] [inserted: In carrying out this subsection, the Director shall convene a consortium of stakeholders, including industry, institutions of higher education, nonprofit organizations, and customers to carry out the following:]
(A) [inserted: Develop and periodically update consensus priorities and best practices, as appropriate, for synthetic nucleic acid procurement screening mechanisms.]
(B) [inserted: Develop roadmaps to inform the activities carried out under paragraph (1).]
(3) [inserted: Report.—] [inserted: Not later than 18 months after the first meeting of the consortium under paragraph (2), the Director shall submit to the Committee on Commerce, Science, and Transportation of the Senate and the Committee on Science, Space, and Technology of the House of Representatives a report summarizing the findings of the consortium.]
(4) [inserted: Authorization of appropriations.—] [inserted: Of the funds authorized to be appropriated for the National Institute of Standards and Technology pursuant to this section for scientific and technical research and services laboratory activities, there is authorized to be appropriated $5,000,000 for each of fiscal years 2027 through 2031 to carry out this subsection.]
[struck: (b)] [inserted: (c)] Rule of construction Nothing in this section may be construed to alter the policies, processes, or practices of individual Federal agencies in effect on the day before August 9, 2022, relating to the conduct or support of biomedical research and advanced development, including the solicitation and review of extramural research proposals.
[struck: (c)] [inserted: (d)] Controls In carrying out activities authorized by this section, the Secretary shall ensure proper security controls are in place to protect sensitive information, as appropriate.